CVS Health installs 14 new medication disposal units inside CVS Pharmacy locations in Rhode Island

WOONSOCKET, R.I., 2018-Mar-08 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (March 6, 2018) that the company has expanded its safe medication disposal program inside select CVS Pharmacy locations in Rhode Island to help facilitate proper and timely disposal of opioids and other medications that could be diverted or misused if left in people’s homes. Attorney General Peter Kilmartin, U.S. Attorney Stephen Dambruch, and Pawtucket Police Chief Tina Goncalves joined representatives from CVS Health at a Pawtucket CVS Pharmacy store to launch the program today.

“With a presence in nearly 10,000 communities across the country, we witness the impact of the alarming and rapidly growing epidemic of opioid addiction and misuse,” said Tom Davis, Vice President of Professional Services for CVS Pharmacy. “Expanding our safe medication disposal efforts in Rhode Island is an extension of the initiatives in place across our company to fight the opioid abuse epidemic and fulfil our purpose of helping people on their path to better health.”

The 14 new medication disposal units that will be installed inside CVS Pharmacy locations in Rhode Island will supplement an additional 14 units CVS Health has donated to police departments across the state. Nationwide, CVS Health has donated more than 850 units to local law enforcement, collecting more than 140 metric tons, or more than 300,000 pounds of unwanted medication.

Attorney General Kilmartin said, “I applaud CVS Health for recognizing that to effectively tackle and defeat the opioid epidemic in this country, all stakeholders need to work together in a coordinated effort. Expanding the company’s prescription drug disposal kiosks to stores across Rhode Island will make it easier for customers to safely dispose of expired, unused, and unwanted prescription opioids and other prescription drugs before they can be abused or diverted for illicit purposes.”

The expansion of the safe medication disposal program to 750 CVS Pharmacy locations across the U.S. was included among the enhancements to the company’s strategy to address and prevent opioid abuse announced in September 2017. As part of that effort, the company also said it would align opioid utilization management with CDC Guideline for CVS Caremark clients and members, complementing measures already in place.

This work builds on ongoing company initiatives, including the Pharmacists Teach program, which brings CVS Pharmacists to local schools to talk to teens and parents about the dangers of abusing prescription drugs. More than 300,000 teens nationally including more than 3,600 in Rhode Island have already participated in the program. CVS Health has also worked to expand access to the opioid overdose-reversal drug naloxone in 46 states, including Rhode Island.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,800 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 94 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

Amy Lanctot
Corporate Communications
(401) 770-2931
Amy.Lanctot@CVSHealth.com

SOURCE: CVS Health

Opioid overdose-reversal medication naloxone now available without prescription at CVS Pharmacy locations in Oklahoma

WOONSOCKET, R.I., 2017-Nov-10 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (November 9, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all of the 77 CVS Pharmacy locations in Oklahoma, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients without an individual prescription under a statewide protocol giving pharmacists prescriptive authority to dispense naloxone.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our pharmacies in Oklahoma we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Services at CVS Pharmacy. “CVS Health is dedicated to helping the communities we serve address and prevent prescription drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”

“In Oklahoma, more adults die of unintentional prescription drug overdoses than in car crashes,” said Congressman Markwayne Mullin. “Now, thanks to the passage of 21st Century Cures Act and the Comprehensive Addiction and Recovery Act, law enforcement, physicians, and prescribers have more tools than ever to fight the opioid crisis. By making this lifesaving drug readily accessible to all Oklahomans, we can reverse the effects of drug overdose and prevent drug overdose tragedies in the future. Our fight against the opioid crisis does not end here, but it’s great to see a commonsense solution that will save the lives of thousands of Oklahomans each year. Just like seatbelts have helped significantly reduce car accident deaths, so will naloxone help reduce the lives tragically lost each year to drug overdose.”

Today’s naloxone announcement builds on CVS Health’s commitment to helping communities address and prevent prescription drug abuse by focusing on prevention and safe medication disposal. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings CVS pharmacists to local schools to talk to students about the dangers of drug abuse. More than 300,000 students across the U.S. have already taken part in the program. High school teachers and administrators can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 800 units to police departments around the country, collecting more than 100 metric tons of unwanted medication. In September, CVS Health announced it would expand the program to 750 locations inside CVS Pharmacies by mid-2018, for a total of 1,550 safe medication disposal locations.

In that recent announcement, the company also said it would enhance opioid utilization management to align with the CDC Guideline for CVS Caremark PBM clients and members, complementing measures already in place. And, the CVS Health Foundation added a $2 million commitment to previous investments in mitigating prescription drug abuse with support for Community Health Centers providing medication-assisted treatment and other addiction recovery services.

With the addition of Oklahoma, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 46 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Oklahoma, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:
Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

CVS Health announces availability of opioid overdose-reversal medication naloxone without prescription at CVS Pharmacy locations in Michigan

WOONSOCKET, R.I., 2017-Nov-10 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (November 9, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all of the nearly 300 CVS Pharmacy locations in Michigan, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients without an individual prescription under a statewide standing order protocol.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our pharmacies in Michigan we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Services at CVS Pharmacy. “CVS Health is dedicated to helping the communities we serve address and prevent prescription drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”

“Michigan families have lost too many loved ones to the opioid epidemic,” said U.S. Senator Debbie Stabenow. “Naloxone is a critical life-saving drug for those who suffer from addiction and I applaud those working to make it more accessible.”

Today’s naloxone announcement builds on CVS Health’s commitment to helping communities address and prevent prescription drug abuse by focusing on prevention and safe medication disposal. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings CVS pharmacists to local schools to talk to students about the dangers of drug abuse. More than 300,000 students across the U.S. have already taken part in the program. High school teachers and administrators can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 800 units to police departments around the country, collecting more than 100 metric tons of unwanted medication. In September, CVS Health announced it would expand the program to 750 locations inside CVS Pharmacies by mid-2018, for a total of 1,550 safe medication disposal locations.

In that recent announcement, the company also said it would enhance opioid utilization management to align with the CDC Guideline for CVS Caremark PBM clients and members, complementing measures already in place. And, the CVS Health Foundation added a $2 million commitment to previous investments in mitigating prescription drug abuse with support for Community Health Centers providing medication-assisted treatment and other addiction recovery services.

With the addition of Michigan, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 46 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Michigan, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:
Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

CVS Health: opioid overdose-reversal medication naloxone now available without prescription at CVS Pharmacy locations in Delaware

WOONSOCKET, R.I., 2017-Nov-10 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (Nov. 9, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at the 20 CVS Pharmacy locations in Delaware, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients without an individual prescription under a statewide standing order protocol.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our pharmacies in Delaware we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Services at CVS Pharmacy. “CVS Health is dedicated to helping the communities we serve address and prevent prescription drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”

“Our first priority is to save lives, and expanding access to this overdose-reversing medication through local pharmacies gives more people in the community the opportunity to help us do that,” said Dr. Karyl Rattay, Director of Delaware Health and Social Services Division of Public Health. “We see no signs of the opioid epidemic slowing and we need all the tools at our disposal to turn the tide.”

Today’s naloxone announcement builds on CVS Health’s commitment to helping communities address and prevent prescription drug abuse by focusing on prevention and safe medication disposal. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings CVS pharmacists to local schools to talk to students about the dangers of drug abuse. More than 300,000 students across the U.S. have already taken part in the program. High school teachers and administrators can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 800 units to police departments around the country, collecting more than 100 metric tons of unwanted medication. In September, CVS Health announced it would expand the program to 750 locations inside CVS Pharmacies by mid-2018, for a total of 1,550 safe medication disposal locations.

In that recent announcement, the company also said it would enhance opioid utilization management to align with the CDC Guideline for CVS Caremark PBM clients and members, complementing measures already in place. And, the CVS Health Foundation added a $2 million commitment to previous investments in mitigating prescription drug abuse with support for Community Health Centers providing medication-assisted treatment and other addiction recovery services.

With the addition of Delaware, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 46 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Delaware, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:
Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

Opioid overdose-reversal medication naloxone now available without prescription at all CVS Pharmacy locations in South Dakota

WOONSOCKET, R.I., 2017-Jul-28 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today ( July 27, 2017) that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all CVS Pharmacy locations in South Dakota. Under a collaborative practice agreement between CVS Pharmacists and a local physician, CVS pharmacies, located inside Target stores in Rapid City and Sioux Falls, can dispense the medication to patients without the need for a separate visit to a prescriber.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our pharmacies in South Dakota we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Services at CVS Pharmacy. “We are dedicated to helping the communities we serve address and prevent prescription drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”

“Increased access to naloxone is an important resource for families struggling with addiction,” said Gary Mendell, founder and CEO of Shatterproof, a non-profit dedicated to reducing the devastation the disease of addiction causes families. “Naloxone is a safe and trusted tool that helps loved ones fight the overdoses that are ravaging our communities. We are pleased to see CVS Health make this life-saving medication available at pharmacies in South Dakota and 41 other states.”

Earlier this year, Shatterproof launched a new website, Shatterproof.org, which provides information about naloxone as well as other resources for those affected by substance use disorder. The launch of the site was supported in part through a grant from the CVS Health Foundation.

Today’s naloxone announcement also builds on CVS Health’s commitment to helping communities address and prevent prescription drug abuse by focusing on prevention and safe medication disposal. In 2015 CVS Health launched a community outreach program called Pharmacists Teach, which brings CVS pharmacists to local schools to talk to students about the dangers of drug abuse. More than 275,000 students across the U.S. have already taken part in the program. High school teachers and administrators can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. Law enforcement officials in South Dakota can apply to receive a drug collection unit at www.cvs.com/safercommunities. Additionally, CVS Health has launched digital resources on its website CVS.com that give patients and families information about drug abuse prevention.

With the addition of South Dakota, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 42 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

Opioid overdose-reversal medicine naloxone now available without prescription at CVS Pharmacies in Iowa

DES MOINES, Iowa, 2017-Mar-31 — /EPR Retail News/ — Today (March 29, 2017), CVS Health officials (NYSE: CVS) joined Iowa Lt. Gov. Kim Reynolds, Department of Public Health Director Gerd Clabaugh and Office of Drug Control Policy Director Steve Lukan in announcing the availability of the opioid overdose-reversal medicine naloxone without a prescription at all CVS Pharmacy locations in Iowa. CVS Health has established a standing order with physicians in Iowa that allows CVS Pharmacy to expand access to the medication in the state.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Iowa pharmacies by the use of a physician’s standing order for patients without a prescription, we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “We support expanding naloxone availability to give more people a chance to get the help they need for recovery and we applaud the State of Iowa for their leadership in the fight against drug abuse and addiction.”

“Thanks to action we have taken in Iowa, first responders, family members, and others can now obtain and administer Naloxone more easily,” said Reynolds. “I want to thank CVS Health for partnering in our multi-faceted approach to combat the opioid epidemic that has affected many Iowans. We need to continue to work together to prevent, treat and respond to this epidemic.”

Today’s naloxone announcement builds on CVS Health’s longstanding commitment to helping communities address and prevent drug abuse. CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. Police departments in Iowa can apply to receive a drug collection unit at www.cvs.com/safercommunities.

Additionally, CVS Health has launched digital resources on its website CVS.com that give patients and families a single destination to learn more about drug abuse prevention. And, in 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 200,000 students have already taken part in the program. High school teachers and administrators in Iowa can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

With the addition of Iowa, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 41 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

Contact:

Carolyn Castel
carolyn.castel@cvshealth.com

SOURCE: CVS Health

Naloxone opioid overdose-reversal drug now available without prescription at all CVS Pharmacy locations in Nevada

WOONSOCKET, R.I., , 2016-Dec-19 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (December 14, 2016) that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Nevada. CVS Health has established a standing order with physicians in Nevada that allows CVS Pharmacy to expand access to the medication across the state.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Nevada pharmacies by the use of a physician’s standing order for patients without a prescription, we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “We are dedicated to helping the communities we serve address and prevent drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”

The move to expand access to naloxone builds on CVS Health’s longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. CVS Health’s commitment to drug abuse prevention education extends from online resources for patients visiting CVS.com to a commitment to youth prevention programs. Launched in 2015, CVS Health’s Pharmacists Teach program gives its pharmacists the opportunity to volunteer to speak to local students about the dangers of drug abuse. More than 150,000 students have already been part of the program. The CVS Health Foundation is also working with DoSomething.org to create a peer-to-peer prevention and intervention program delivered to young people via text message and online.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 600 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 47 metric tons of prescription drugs.

“CVS Health has been a leader in the work of helping communities prevent prescription drug abuse,” said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. “In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction.”

With the addition of Nevada, CVS Pharmacy now dispenses naloxone in a total of 37 states: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

Opioid overdose-reversal drug naloxone now available in CVS pharmacies in Alabama, Alaska, Illinois, Missouri and West Virginia

WOONSOCKET, R.I., 2016-Oct-03 — /EPR Retail News/ — CVS Health (NYSE: CVS) today (September 29, 2016) announced it has expanded access to the opioid overdose-reversal drug naloxone in Alabama, Alaska, Illinois, Missouri and West Virginia, allowing CVS Pharmacy patients to access the medication without an individual prescription. In total, CVS Pharmacy patients in 36 states now have increased access to the life-saving opioid overdose-reversal drug. CVS Health’s naloxone program establishes a standing order with a physician in the state or utilizes pharmacists’ prescriptive authority to permit CVS Pharmacists to dispense naloxone to patients without an individual prescription. Pharmacists in these five states began dispensing the medication this week.

“Naloxone is a safe and effective antidote to opioid overdose and by expanding availability of this medication, we can save lives and give more people a chance to get the help they need for recovery,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “By establishing a physician-authorized standing order that allows our pharmacies to dispense naloxone to patients without an individual prescription, we strengthen our commitment to helping the communities we serve begin to address the challenges of prescription drug abuse.”

“Expanding access to the overdose-reversal drug naloxone is a critical part of our national strategy to stop the prescription drug and heroin overdose epidemic along with effective prevention, treatment, and enforcement,” said Michael Botticelli, Director of National Drug Control Policy. “Thanks to efforts on naloxone like those announced today by CVS Health, more Americans will have access to this lifesaving drug.”

The move to expand access to naloxone builds on CVS Health’s longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. CVS Health’s commitment to drug abuse prevention education extends from online resources launched for patients visiting CVS.com to two robust youth prevention programs. Launched last year, CVS Health’s Pharmacists Teach program gives its pharmacists the opportunity to volunteer to speak to high school health classes about the dangers of drug abuse. More than 100,000 students have already been part of the program. Recently, the company also announced a partnership with DoSomething.org to create a peer-to-peer prevention and intervention program delivered to young people via text message and online.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 600 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 47 metric tons of prescription drugs.

“CVS Health has been a leader in the work of helping communities prevent prescription drug abuse,” said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. “In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction.”

With the addition of the five new states where CVS Pharmacy locations began dispensing naloxone to patients without a prescription this week, CVS Pharmacy locations in the following 36 states now offer naloxone: Alabama, Alaska, Arkansas,California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana, Kentucky,Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana,New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota,Ohio, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Vermont,Virginia, Washington, West Virginia and Wisconsin. CVS Health also plans to further expand its naloxone program to other states in the coming months.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:
Erin Shields Britt
Corporate Communications
401-770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

CVS Health: opioid overdose-reversal drug naloxone now available without prescription at all its pharmacies in Washington

WOONSOCKET, R.I., 2016-Sep-15 — /EPR Retail News/ — CVS Health (NYSE: CVS) announced today (Sept. 14, 2016) that the opioid overdose-reversal medication naloxone is now available for patients without a prescription at all CVS Pharmacy locations in Washington. Under a collaborative agreement with a physician in the state, CVS pharmacists can exercise prescriptive authority to dispense the medication. In addition to Washington, CVS Pharmacy locations in 30 other states are able to dispense naloxone to patients without an individual prescription. The company’s move to increase access to naloxone builds on its other efforts to reduce drug abuse, including prevention education and safe drug disposal.

“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Washington pharmacies for patients without a prescription, we can help save lives,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “We are dedicated to helping the communities we serve address and prevent drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”

“The impact of drug abuse has been felt by our families and friends across the state of Washington. It is a crisis that impacts people of every age, income level and race and involves prescription medications and illegal drugs,” Governor Jay Inslee said. “I commend CVS for making the lifesaving opioid overdose reversal drug Naloxone available directly from a pharmacist, and for providing safe disposal options for unwanted medications. To address this epidemic we need the public and private sector working together on options such as this for our communities. Please visit www.stopoverdose.org to learn how to prevent and respond to an opioid overdose.”

Efforts to increase access to naloxone build on CVS Health’s longstanding commitment to helping communities address and prevent drug abuse. CVS Health has joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. Law enforcement officials across Washington can apply to receive a drug collection unit here.

In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 100,000 students have already taken part in the program. High school teachers and administrators in Washington can learn more about bringing Pharmacists Teach to their school here.

And, CVS Health has launched digital resources online at www.cvs.com/content/prescription-drug-abuse, giving patients and families a single destination to learn more about drug abuse prevention.

About CVS Health

CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE: CVS Health

CVS Health expands access to opioid overdose-reversal drug naloxone in seven additional states this summer

WOONSOCKET, R.I., 2016-May-25 — /EPR Retail News/ — CVS Health (NYSE: CVS) today announced it will expand access to the opioid overdose-reversal drug naloxone in seven additional states this summer, contributing to a total of 30 states where the life-saving medication will be more accessible to CVS Pharmacy patients. CVS Health’s naloxone program establishes a standing order with a physician in the state, which permits CVS Pharmacists to dispense naloxone to patients without an individual prescription.

“Naloxone is a safe and effective antidote to opioid overdose and by expanding availability of this medication, we can save lives and give more people a chance to get the help they need for recovery,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. “By establishing a physician-authorized standing order that allows our pharmacies to dispense naloxone to patients without an individual prescription, we strengthen our commitment to helping the communities we serve begin to address the challenges of prescription drug abuse.”

Expansion of the company’s naloxone program will begin with New Mexico in late May; followed by Louisiana in early June; Florida in early July; Colorado, Idaho andOregon in mid-July; and Washington in early August. Naloxone is already available without a prescription at CVS Pharmacy locations through standing order or collaborative practice agreements in 23 states: Arkansas, California, Connecticut,Indiana, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Montana, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio,Pennsylvania, Rhode Island, Tennessee, Utah, Vermont, Virginia and Wisconsin.

“Expanding access to the overdose-reversal drug naloxone is a critical part of our national strategy to stop the prescription drug and heroin overdose epidemic along with effective prevention, treatment, and enforcement,” said Michael Botticelli, Director of National Drug Control Policy. “Thanks to efforts on naloxone like those announced today by CVS Health, more Americans will have access to this lifesaving drug.”

The move to expand access to naloxone builds on CVS Health’s longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. Patients visiting CVS.com can find recently launched drug abuse prevention resources for themselves and their families. The company has also launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 80,000 students have already been part of the program. High schools across the country can learn more about bringing Pharmacists Teach to their school here.

CVS Health has also joined with the Partnership for Drug-Free Kids for the Medication Disposal for Safer Communities Program, which has donated more than 500 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 35 metric tons of prescription drugs. Police departments across the country can apply to receive a drug collection unit from the program here.

“CVS Health has been a leader in the work of helping communities prevent prescription drug abuse,” said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. “In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction.”

About CVS Health:
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:
Erin Shields Britt
Corporate Communications
401-770-9237
Erin.Britt@CVSHealth.com

SOURCE CVS Health